Sign in
Active, not recruitingPhase 1/2

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Key facts

Who runs it
Portland VA Research Foundation, Inc
Where
Vancouver, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 1/2
People taking part
30 people, planned
Started
7 Jul 2022
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Psilocybin
  • Treatment-as-usual
Record updated
22 April 2026

Who can take part

Age
25 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • United States military Veteran
  • Moderate to severe methamphetamine use disorder using the DSM-V diagnostic criteria
  • Desire to cease or reduce methamphetamine use

Who cannot take part

  • Taking certain medications that may interact with psilocybin
  • Have uncontrolled hypertension or clinically significant cardiovascular disease
  • History of seizure disorder in adulthood
  • CNS metastases or symptomatic central nervous system (CNS) infection
  • Poorly controlled diabetes mellitus
  • History of any primary persistent psychotic disorder, including schizophrenia, schizoaffective disorder, bipolar disorder with psychosis, major depressive disorder with psychosis, or schizophreniform disorder
  • History of bipolar I disorder
  • Current eating disorder with active purging
  • History of hallucinogen use disorder
  • Pregnant or breast feeding

Where in United States

  • Portland VA Health Care SystemVancouver, United States

About the trial

What the trial wants to find out

This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.

The 2 groups in the trial

  • Psilocybin-enhanced psychotherapyTreatment being tested

    Psilocybin will be administered twice (25mg \& 30mg two weeks apart) in addition to a 6-week psychotherapy protocol while admitted to a residential rehabilitation treatment program.

    Treatment: Psilocybin and Treatment-as-usual

  • Treatment-as-UsualOther group

    Treatment-as-usual while admitted to a residential rehabilitation treatment program.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
22 April 2026